MENU
VERV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Verve Therapeutics (VERV) Earnings Date & Reports

A.I. Advisor
published Earnings

VERV is expected to report earnings to rise 21.15% to -71 cents per share on February 26

Verve Therapeutics VERV Stock Earnings Reports
Q4'24
Est.
$-0.71
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.11
Q4'23
Beat
by $0.14
The last earnings report on November 05 showed earnings per share of -58 cents, beating the estimate of -68 cents. With 588.73K shares outstanding, the current market capitalization sits at 455.49M.
View a ticker or compare two or three
VERV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 617 603-0070
Employees
255
Web
https://www.vervetx.com